Advice on offers

Hey guys, I am quite conflicted between the two offers. Both offers are right out of undergrad in the UK. I have no plan of getting an MBA. I'm not crazy about PE and would be more interested in public markets (HF/LO). 

A. Eaton Vance (MSIM) Research role (equity) - the team seems nice and more interesting work than IBD. My concern is whether I can do the job well as I didn't have prior research experience. I was wondering what the mobility is like for a LO role (thinking of going to Asia long term). Wouldn't hesitate to take it if it were a tier 1 AM offer but I'm not sure if EV is better than the IBD offer I have. 

B. Top 3 BB IBD - obvious pros and cons. 

Any input is appreciated!

7 Comments
 

EV is a good shop and being added to the MS umbrella will only increase its stance. I think either will give you the same LO/HF exits but IBD will give you more outside of LO/HF (if you change your mind).

If you're not interested, I say save yourself the IBD headache, buyside is most people's end goal. I would guess that switching internally to IBD at MS wouldn't be the hardest if you wanted to change your mind a year or two in

 

Laboriosam culpa blanditiis odio accusamus vitae voluptatem. Delectus et vero non. Sequi vitae accusantium vel neque. Quo qui fugit adipisci qui et.

Aut quibusdam voluptatibus fugiat dolor. Officia quaerat assumenda quia quas aliquid soluta enim labore. Tempore ut dolore quod ea rem.

Quis harum voluptatibus rerum pariatur consectetur quas perferendis. Est omnis consequatur aut blanditiis.

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (73) $101

Leaderboard